A Multidisciplinary Approach to CAR T-cell Therapy for Adult Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia
home / insights / a-multidisciplinary-approach-to-car-t-cell-therapy-for-adult-relapsed-or-refractory-b-cell-acute
EP. 1: CAR T-cell Therapy for B-ALL
December 24th 2024A panelist discusses how CAR-T cell therapy patient selection involves evaluating disease characteristics like relapse/refractory status and tumor burden, patient-specific factors including performance status and organ function, with extramedullary disease requiring careful monitoring while isolated CNS disease may warrant alternative treatments or clinical trials.
